Speakers

Andrew Clutterbuck

MERCK

MSAT Director, EMEA

Andrew Clutterbuck serves as the Director of Merck’s Manufacturing Sciences & Technology (MSAT) group for the Europe, Middle East, and Africa regions. With 25 years of experience in biomanufacturing, he has a comprehensive background that spans from process development to cGMP manufacturing. Andrew joined Merck in 2011, bringing with him a wealth of expertise gained from various development and manufacturing roles at contract manufacturing organizations in the UK, where he focused on developing, scaling, and manufacturing biopharmaceuticals. He holds a degree in Molecular & Cellular Biology from the University of Huddersfield, UK.

Building the Flexible Biologics Factory of the Future

Advancing Formulation and Fill-Finish through Single-Use Technologies

As biologics pipelines diversify and product lifecycles shorten, manufacturers must increase flexibility, accelerate time-to-market, and optimise capital investment. Single-use technologies have become a key enabler, extending beyond upstream and downstream processing into formulation and fill-finish operations.

This presentation explores how advances in single-use technologies are shaping modern formulation and filling suites. By enabling flexible fluid management and streamlined workflows, these solutions simplify facility design, reduce operational complexity, and support rapid product changeovers.

Drawing on industry trends and project experience, the discussion will highlight key design considerations, implementation challenges, and strategies for improving manufacturing agility.

Merck

Sparking Discovery, Elevating Humanity

Merck is a vibrant team of specialists in Electronics, Healthcare and Life Science. They share a love of science and a passion for technology, and believe in science as a force for good.

In our rapidly changing and uncertain world, factors such as an aging population, chronic diseases, AI, climate change, and other megatrends have created an appetite for scientific breakthroughs that can make a positive difference across our global society. The pace of change will increase over coming decades as technologies evolve and converge in ways that fundamentally transform how we live and work. At Merck, change is not a threat but an opportunity as they have proven for over more than 350 years.

Visit the website of Merck